Skip to main content
Erschienen in: Irish Journal of Medical Science (1971 -) 3/2017

04.01.2017 | Original Article

Antibiotic resistance patterns of Escherichia coli urinary isolates and comparison with antibiotic consumption data over 10 years, 2005–2014

verfasst von: P. J. Stapleton, D. J. Lundon, R. McWade, N. Scanlon, M. M. Hannan, F. O’Kelly, M. Lynch

Erschienen in: Irish Journal of Medical Science (1971 -) | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Escherichia coli is a common cause of urinary tract infections (UTI). Reviews of antibiotic resistance of this organism can inform choice of empiric treatment of UTI and other infections and strategies for combating antimicrobial resistance. We reviewed laboratory and hospital pharmacy records to assess trends in non-susceptibility rates and the effect of antimicrobial stewardship interventions.

Methods

A retrospective observational study of isolates of E. coli from MSU samples at a Dublin teaching hospital from inpatients and community, obtained from January 2005 to December 2014. Susceptibility to a panel of antibiotics was determined using the disc diffusion method, as well as extended-spectrum beta-lactamase (ESBL) production status. Trends in resistance were plotted graphically and analysed in a descriptive manner.

Results

Except for nitrofurantoin and gentamicin, non-susceptibility increased for all antimicrobials tested. Co-amoxiclav non-susceptibility reached 48% in hospital and 32.6% in the community by 2014. Piperacillin–tazobactam non-susceptibility increased from 6.8 to 23.8% in hospital and from <1 to 12.5% in community, with similar increases for ESBL producing isolates. Ciprofloxacin non-susceptibility peaked at 25.5% in hospital in 2012 and 11.44% in the community in 2014.

Conclusion

Escherichia coli isolates from community MSU samples have high rates of non-susceptibility to trimethoprim and co-amoxiclav. Nitrofurantoin remains the best empiric therapy for cystitis. Increasing non-susceptibility to co-amoxiclav and piperacillin–tazobactam in hospital isolates is concerning. Ciprofloxacin non-susceptibility is increasing faster in the community than in hospital. A sharp reduction in hospital fluoroquinolone consumption did not result in a significant reduction in ciprofloxacin non-susceptibility of hospital E. coli isolates.
Literatur
2.
Zurück zum Zitat European Centre for Disease Prevention and Control, Antimicrobial resistance surveillance in Europe (2012) Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). European Centre for Disease Prevention and Contro, Stockholm European Centre for Disease Prevention and Control, Antimicrobial resistance surveillance in Europe (2012) Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). European Centre for Disease Prevention and Contro, Stockholm
6.
Zurück zum Zitat Lawes T, Lopez-Lozano J-M, Nebot CA et al (2015) Effects of national antibiotic stewardship and infection control strategies on hospital-associated and community-associated meticillin-resistant Staphylococcus aureus infections across a region of Scotland: a non-linear time-series study. Lancet Infect Dis 15:1438–1449. doi:10.1016/S1473-3099(15)00315-1 CrossRefPubMed Lawes T, Lopez-Lozano J-M, Nebot CA et al (2015) Effects of national antibiotic stewardship and infection control strategies on hospital-associated and community-associated meticillin-resistant Staphylococcus aureus infections across a region of Scotland: a non-linear time-series study. Lancet Infect Dis 15:1438–1449. doi:10.​1016/​S1473-3099(15)00315-1 CrossRefPubMed
8.
Zurück zum Zitat Livermore DM, Hope R, Reynolds R et al (2013) Declining cephalosporin and fluoroquinolone non-susceptibility among bloodstream Enterobacteriaceae from the UK: links to prescribing change? J Antimicrob Chemother 68:2667–2674. doi:10.1093/jac/dkt212 CrossRefPubMed Livermore DM, Hope R, Reynolds R et al (2013) Declining cephalosporin and fluoroquinolone non-susceptibility among bloodstream Enterobacteriaceae from the UK: links to prescribing change? J Antimicrob Chemother 68:2667–2674. doi:10.​1093/​jac/​dkt212 CrossRefPubMed
9.
Zurück zum Zitat CLSI (2012) Performance Standards for Antimicrobial Disk Susceptibility Tests, Approved Standard–Eleventh Edition. CLSI Document M02–A11. Clinical and Laboratory Standards Institute, Wayne CLSI (2012) Performance Standards for Antimicrobial Disk Susceptibility Tests, Approved Standard–Eleventh Edition. CLSI Document M02–A11. Clinical and Laboratory Standards Institute, Wayne
10.
Zurück zum Zitat CLSI (2012) Performance Standard for Antimicrobial Disk Susceptibility Testing. Twenty-Second Informational supplement. CLSI document No. M100-S2 CLSI. Clinical and Laboratory Standards Institute CLSI (2012) Performance Standard for Antimicrobial Disk Susceptibility Testing. Twenty-Second Informational supplement. CLSI document No. M100-S2 CLSI. Clinical and Laboratory Standards Institute
11.
13.
Zurück zum Zitat Chulain MN, Murray A-M, Corbett-Feeney G, Cormican M (2004) Antimicrobial resistance in E. coli associated with urinary tract infection in the west of Ireland. Ir J Med Sci 174(4):6–9CrossRef Chulain MN, Murray A-M, Corbett-Feeney G, Cormican M (2004) Antimicrobial resistance in E. coli associated with urinary tract infection in the west of Ireland. Ir J Med Sci 174(4):6–9CrossRef
14.
Zurück zum Zitat Gupta K, Hooton TM, Naber KG et al (2011) International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 52:e103–e120. doi:10.1093/cid/ciq257 CrossRefPubMed Gupta K, Hooton TM, Naber KG et al (2011) International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 52:e103–e120. doi:10.​1093/​cid/​ciq257 CrossRefPubMed
16.
Zurück zum Zitat Cullen IM, Manecksha RP, McCullagh E et al (2013) An 11-year analysis of the prevalent uropathogens and the changing pattern of Escherichia coli antibiotic resistance in 38,530 community urinary tract infections, Dublin 1999-2009. Ir J Med Sci 182:81–89. doi:10.1007/s11845-012-0834-5 CrossRefPubMed Cullen IM, Manecksha RP, McCullagh E et al (2013) An 11-year analysis of the prevalent uropathogens and the changing pattern of Escherichia coli antibiotic resistance in 38,530 community urinary tract infections, Dublin 1999-2009. Ir J Med Sci 182:81–89. doi:10.​1007/​s11845-012-0834-5 CrossRefPubMed
17.
Zurück zum Zitat Vellinga A, Galvin S, Duane S et al (2016) Intervention to improve the quality of antimicrobial prescribing for urinary tract infection: a cluster randomized trial. CMAJ 188:108–115. doi:10.1503/cmaj.150601 CrossRefPubMed Vellinga A, Galvin S, Duane S et al (2016) Intervention to improve the quality of antimicrobial prescribing for urinary tract infection: a cluster randomized trial. CMAJ 188:108–115. doi:10.​1503/​cmaj.​150601 CrossRefPubMed
19.
Zurück zum Zitat Sundqvist M, Geli P, Andersson DI et al (2010) Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use. J Antimicrob Chemother 65:350–360. doi:10.1093/jac/dkp387 CrossRefPubMed Sundqvist M, Geli P, Andersson DI et al (2010) Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use. J Antimicrob Chemother 65:350–360. doi:10.​1093/​jac/​dkp387 CrossRefPubMed
20.
Zurück zum Zitat Vellinga A, Murphy AW, Hanahoe B et al (2010) A multilevel analysis of trimethoprim and ciprofloxacin prescribing and resistance of uropathogenic Escherichia coli in general practice. J Antimicrob Chemother 65:1514–1520. doi:10.1093/jac/dkq149 CrossRefPubMed Vellinga A, Murphy AW, Hanahoe B et al (2010) A multilevel analysis of trimethoprim and ciprofloxacin prescribing and resistance of uropathogenic Escherichia coli in general practice. J Antimicrob Chemother 65:1514–1520. doi:10.​1093/​jac/​dkq149 CrossRefPubMed
21.
Zurück zum Zitat Cullen IM, Manecksha RP, McCullagh E et al (2012) The changing pattern of antimicrobial resistance within 42°033 Escherichia coli isolates from nosocomial, community and urology patient-specific urinary tract infections, Dublin, 1999–2009. BJU Int 109:1198–1206. doi:10.1111/j.1464-410X.2011.10528.x CrossRefPubMed Cullen IM, Manecksha RP, McCullagh E et al (2012) The changing pattern of antimicrobial resistance within 42°033 Escherichia coli isolates from nosocomial, community and urology patient-specific urinary tract infections, Dublin, 1999–2009. BJU Int 109:1198–1206. doi:10.​1111/​j.​1464-410X.​2011.​10528.​x CrossRefPubMed
22.
Zurück zum Zitat Ironmonger D, Edeghere O, Bains A et al (2015) Surveillance of antibiotic susceptibility of urinary tract pathogens for a population of 5.6 million over 4 years. J Antimicrob Chemother 70:1744–1750. doi:10.1093/jac/dkv043 PubMed Ironmonger D, Edeghere O, Bains A et al (2015) Surveillance of antibiotic susceptibility of urinary tract pathogens for a population of 5.6 million over 4 years. J Antimicrob Chemother 70:1744–1750. doi:10.​1093/​jac/​dkv043 PubMed
23.
Zurück zum Zitat Badura A, Feierl G, Pregartner G et al (2015) Antibiotic resistance patterns of more than 120,000 clinical Escherichia coli isolates in Southeast Austria, 1998–2013. Clin Microbiol Infect 21:569.e-1. doi:10.1016/j.cmi.2015.02.012 CrossRef Badura A, Feierl G, Pregartner G et al (2015) Antibiotic resistance patterns of more than 120,000 clinical Escherichia coli isolates in Southeast Austria, 1998–2013. Clin Microbiol Infect 21:569.e-1. doi:10.​1016/​j.​cmi.​2015.​02.​012 CrossRef
Metadaten
Titel
Antibiotic resistance patterns of Escherichia coli urinary isolates and comparison with antibiotic consumption data over 10 years, 2005–2014
verfasst von
P. J. Stapleton
D. J. Lundon
R. McWade
N. Scanlon
M. M. Hannan
F. O’Kelly
M. Lynch
Publikationsdatum
04.01.2017
Verlag
Springer London
Erschienen in
Irish Journal of Medical Science (1971 -) / Ausgabe 3/2017
Print ISSN: 0021-1265
Elektronische ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-016-1538-z

Weitere Artikel der Ausgabe 3/2017

Irish Journal of Medical Science (1971 -) 3/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.